Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Cogstate Ltd ( (AU:CGS) ) just unveiled an update.
Cogstate Ltd has announced an update on its ongoing share buy-back program, with a total of 3,961,629 securities bought back before the previous day and an additional 32,862 securities purchased on the previous day. This buy-back initiative reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value, which could have implications for its market positioning and investor relations.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, primarily focusing on cognitive science and the development of digital brain health assessments. The company provides services and products aimed at improving brain health and cognitive performance, catering to both clinical trials and healthcare markets.
YTD Price Performance: 20.88%
Average Trading Volume: 10,267
Technical Sentiment Signal: Sell
Current Market Cap: $149.2M
Learn more about CGS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue